The heterozygous Sod2(+/-) mouse: modeling the mitochondrial role in drug toxicity

Urs A Boelsterli1, Chin-Ju J Hsiao

  • 1University of Connecticut, School of Pharmacy, Department of Pharmaceutical Sciences, Storrs, CT 06269-3092, United States. urs.boelsterli@uconn.edu

Drug Discovery Today
|September 3, 2008
PubMed

Insights

Mitochondrial dysfunction, particularly involving superoxide dismutase-2 (SOD2), plays a key role in drug-induced liver injury. SOD2 deficiency models offer insights into silent mitochondrial abnormalities and drug toxicity mechanisms.

Area of Science:

  • Mitochondrial biology
  • Toxicology
  • Genetics

Background:

  • Mitochondria are key targets in drug-induced oxidative injury.
  • Superoxide dismutase-2 (SOD2) is a critical mitochondrial antioxidant.
  • SOD2 deficiency models are valuable for studying mitochondrial stress.

Purpose of the Study:

  • To investigate the role of SOD2 in drug-induced liver injury.
  • To explore the utility of SOD2-deficient mouse models in toxicology research.

Main Methods:

  • Genetic modification (transgenic techniques, gene silencing) to create SOD2 deficiency.
  • Utilizing heterozygous Sod2(+/-) knockout mice.
  • Application of these models to study drug-induced liver injury.

Main Results:

  • SOD2 deficiency models exhibit subtle mitochondrial stress without overt phenotypic abnormalities.
  • These models successfully illuminate mechanisms of idiosyncratic drug-induced liver injury.
  • The models are applicable to oxidative stress and age-related research.

Conclusions:

  • Mitochondrial dysfunction, mediated by SOD2, is central to drug toxicity.
  • SOD2 knockout mice are effective models for studying drug-induced liver injury.
  • Further research can leverage these models for understanding mitochondrial disease and aging.

Related Concept Videos

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
Lethal Alleles02:41

Lethal Alleles

Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Incomplete Dominance01:43

Incomplete Dominance

Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.